Traditional sensor technology struggles at the subtleties, missing faint signals that could be game-changers in detection and analysis. This shortfall partially explains the absence of biosensors throughout COVID-19 pandemic.
The significant expense associated with enhancing sensor response has made potential sensor applications cost-prohibitive and has stalled advancements in fields such as infrared sensing.
Despite their rapid response times and inherent high sensitivity, the semiconductor industry currently lacks semiconductor-based biosensor technology that diagnostic companies can adopt.
Solution 01
Revolutionize Sensitivity : Catch the Whisper of Change
Introducing Barristor: the sensor technology breakthrough that makes the undetectable, detectable, and the once impossible, possible – all while being affordable.
Solution 02
Precision in the Palm of Your Hand : The Future of Biosensing
Break free from market constraints with Barristor technology – where advanced detection meets cost-effective implementation, even in a pandemic.
Solution 03
Unify Your Sensing Solutions : One Platform, Infinite Possibilities
Break free from market constraints with Barristor technology – where advanced detection meets cost-effective implementation, even in a pandemic.
PROCESS
Solution 01
Revolutionize Sensitivity : Catch the Whisper of Change
Introducing Barristor: the sensor technology breakthrough that makes the undetectable, detectable, and the once impossible, possible – all while being affordable.
Solution 02
Precision in the Palm of Your Hand : The Future of Biosensing
Break free from market constraints with Barristor technology – where advanced detection meets cost-effective implementation, even in a pandemic.
Solution 03
Unify Your Sensing Solutions : One Platform, Infinite Possibilities
Break free from market constraints with Barristor technology – where advanced detection meets cost-effective implementation, even in a pandemic.
Traditional sensor technology struggles at the subtleties, missing faint signals that could be game-changers in detection and analysis. This shortfall partially explains the absence of biosensors throughout COVID-19 pandemic.
The significant expense associated with enhancing sensor response has made potential sensor applications cost-prohibitive and has stalled advancements in fields such as infrared sensing.
Despite their rapid response times and inherent high sensitivity, the semiconductor industry currently lacks semiconductor-based biosensor technology that diagnostic companies can adopt.